Correction: Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience - Top-Institutions - MDSpire

Correction: Real-World Insights on Multiple Myeloma: Prognostic Importance of 1q21 Chromosomal Abnormalities - Experience from a Single Center

By
Aleksandra Sretenovic
Marko Mitrovic
Zoran Bukumiric
Nikola Vukosavljevic
Natalija Kecman
Jelica Jovanovic
Marija Dencic Fekete
Enisa Zaric
Jelena Bila
July 21, 2026

Frontiers In Oncology

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic Rochester

Rochester, Minnesota
Key Differentiators
- Hematology
#2

University Hospital Brno

Brno, Czech Republic
Key Differentiators
- Hematology
#3

Ohio State University

Columbus, Ohio
Key Differentiators
- Hematology
#4

MD Anderson Cancer Center

Houston, Texas
Key Differentiators
- Hematology
#5

University of Texas MD Anderson

Houston, Texas
Key Differentiators
- Hematology

Original Source(s)

Frontiers In Oncology

Correction: Multiple myeloma in the real world settings: prognostic significance of 1q21 chromosomal abnormalities - single center experience

by Aleksandra Sretenovic, Marko Mitrovic, Zoran Bukumiric, Nikola Vukosavljevic, Natalija Kecman, Jelica Jovanovic, Marija Dencic Fekete, Enisa Zaric, Jelena Bila
July 21, 2026

Related Content

Frontiers In Oncology

Inflammatory myofibroblastic tumour: unravelling the interplay of inflammation, kinase signalling, and therapeutic resistance

Frontiers In Oncology

Efficacy and safety analysis of immune checkpoint inhibitors combined with chemotherapy in the treatment of advanced triple-negative breast cancer: an umbrella meta-analysis

by Wendi Cao, Qingxi Rong, Yingheng Song, Zhijun Ma, Qiuxia Dong
July 21, 2026

The Medicine Maker

The Power List 2026 is Live

We celebrate 60 inspiring individuals helping turn pharma’s boldest ideas into reality

July 21, 2026
1 min